From the Adult Diabetes and Clinical Research Sections, Joslin Diabetes Center, Harvard Medical School. Approved May 10, 2016; updated April 24, 2018. For the Figure and Tables, download the PDF at the end of the chapter.
June 2018
From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts. This guideline was revised and approved May 17, 2017, and updated February 7, 2018.
CHAPTER 3. Guideline for Detection and Management of Diabetes in Pregnancy
ByFlorence M. Brown, MD,Sue-Ellen Anderson-Haynes, RD, CDE,Elizabeth Blair, MSN, ANP-BC, CDE, CDTC,Shanti Serdy, MD,Elizabeth Halprin, MD,Anna Feldman, MD,Karen E. O'Brien, MD,Sue Ghiloni, RN, CDE,Emmy Suhl, MEd, RD, CDE,Jo-Anne Rizzotto, MEd, RD, CDE,Om P. Ganda, MD, Chair, Clinical Oversight Committee,Robert A. Gabbay, MD, PhD, FACP,members of the Joslin Clinical Oversight Committee, with administrative support from Breda Curran
From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts
From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.
From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.
Listed below are members of the Clinical Oversight Committee and Working Groups who participated in development of the Clinical Guidelines for Joslin Diabetes Center. Faculty who participated in guideline development who are no longer at Joslin are designated with an asterisk.
Om P. Ganda, MD, serves as chair of the Joslin Clinical Oversight Committee, and Robert A. Gabbay, MD, PhD, FACP, is senior vice president and chief medical officer of Joslin Diabetes Center.
Advertisement
Advertisement
Trending on AJMC
1
2025 Nobel Prize in Medicine Honors Discoveries Behind Regulatory T Cells
2
FDA Expands Roflumilast Use for Atopic Dermatitis to Children Aged 2 to 5 Years
3
Aggressive Therapy Recommendations Following the STRONG-HF Trials: Stephen J. Green, MD
4
Pricing and Insurance Networks in Outpatient Surgery Markets
5
